• Eco Animal Health CEO David Hallas Shares Updates on Financial Performance and Product Innovations

  • Jul 16 2024
  • Length: 7 mins
  • Podcast

Eco Animal Health CEO David Hallas Shares Updates on Financial Performance and Product Innovations By cover art

Eco Animal Health CEO David Hallas Shares Updates on Financial Performance and Product Innovations

Listen for free

View show details

  • Summary

  • Eco Animal Health CEO David Hallas joined Steve Darling from Proactive to provide updates on the company’s impressive financial performance and innovative product developments. Eco Animal Health, a leading provider of animal medicines primarily for poultry and swine, is dedicated to ensuring animal health and contributing to the welfare and profitability of producers worldwide. One of the company’s flagship products, Aivlosin, is marketed in over 70 countries, effectively treating respiratory and enteric diseases in pigs and poultry. Hallas highlighted the company's ongoing efforts to innovate and expand its product offerings. A significant development is the new vaccine platform named Eco Vaccine. The first product under this platform is expected to be submitted for licensing in the United States in early 2025, with approvals anticipated by the third quarter of the same year. Additionally, the product will seek licensing in Canada, several Latin American countries, and parts of Asia. Hallas also shared insights into Eco Animal Health's strong financial performance, particularly noting substantial growth in the Americas. The company reported a 22% increase in North America and a 10% rise in Latin America. Hallas attributed this success to an effective team and a competitive market strategy, especially in key markets like Brazil and Mexico. Eco Animal Health maintains a robust cash balance, which facilitates ongoing investments in research and development (R&D) and strategic expansion initiatives. The company is actively recruiting new staff and establishing partnerships with new distributors in regions such as Indonesia, the Philippines, and Vietnam. Expressing optimism about the company’s future, Hallas emphasized Eco Animal Health’s commitment to supporting global nutritional needs through their innovative products. With a focus on continued growth and development, the company is well-positioned to make significant contributions to animal health and the agricultural industry as a whole. #proactiveinvestors #ecoanimalhealthgroupplc #aim #eah #DavidHallas, #PoultryMedicine, #SwineHealth, #AnimalHealth, #Aivlosin, #EcoVaccine, #FinancialGrowth, #ProductDevelopment, #RDInvestment, #AmericasGrowth, #NorthAmerica, #LatinAmerica, #NewDistributors, #AnimalWelfare, #NutritionalNeeds, #VaccinePipeline, #VeterinaryMedicine, #CompanyExpansion, #CEOInterview#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    Show more Show less
activate_primeday_promo_in_buybox_DT
Business & Careers Economics Personal Finance Politics & Government
Show more Show less

What listeners say about Eco Animal Health CEO David Hallas Shares Updates on Financial Performance and Product Innovations

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available